FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc. to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• NAFTIN (NAFTIFINE HYDROCHLORIDE)

Snippet

SUPPL AP for NAFTIN (NAFTIFINE HYDROCHLORIDE)